The national development and reform commission released statistics on Feb 28: In 2012, the industrial output value of China's pharmaceutical industry, foreign trade, economic benefits and completed investment continued to maintain steady growth, showing a steady development trend overall.
By the end of 2012, China's pharmaceutical industry had total assets of 164.08 billion yuan, up 18.4 % year-on-year. In 2012, the output value reached 1825.5 billion yuan, up 21.7 % year-on-year. Of this total, 330.5 billion yuan was used as the original drug of chemical drugs, up by 16.6% year on year. Chemical pharmaceutical preparations reached 508.9 billion yuan, an increase of 24.7 %. Chinese herbal slices reached 102 billion yuan, up 26.4 %. Chinese patent medicines reached 413.6 billion yuan, up 21.3 %. Biochemical drugs reached 185.3 billion yuan, up by 20.5 percent. Medical devices reached 157.3 billion yuan, up 20.6 %. During the same period, the added value of pharmaceutical industry increased by 14.5%, 4.5 percentage points higher than industrial growth.
In 2012, the pharmaceutical industry achieved revenue of 1795 billion yuan, up 20.1 percent year-on-year; Profits totaled 183.3 billion yuan, up 20.4 % year-on-year, and remained at a high level. Among them, the growth rate of Chinese medicine decoction slices and chemical preparations was 27.5% and 25.3%, respectively. The growth rate of chemical raw drug, Chinese patent drug and biological and biochemical drug was slightly lower, 15.9%, 16.9% and 14.3%, respectively. In the same period, the profit margin of pharmaceutical industry sales revenue was about 10.2%, which was basically flat year-on-year.
In 2012, pharmaceutical industry investment continued to grow rapidly, with a total investment of 356.5 billion yuan, up 34.6% year on year, about 14 percentage points higher than that of total fixed asset investment.
In the same period, due to the decline in demand in Europe and the United States and the improvement of import standards in some countries, the growth rate of the import and export trade of the pharmaceutical industry dropped significantly. China's exports and imports totaled $81 billion, up 10.5 percent year on year. Of this, $47.6 billion was exported, up 6.9 percent year on year. Imports rose 15.9 percent to $33.4 billion.
width="35">
width="35">
Our Company
